Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
The Journal of Investigative Dermatology|April 24, 2017
Blockade of PDGF Receptors by Crenolanib Has Therapeutic Effect in Patient Fibroblasts and in Preclinical Models of Systemic SclerosisKatsunari Makino, Tomoko Makino, Lukasz Stawski, et al.The Journal of Investigative Dermatology|September 19, 2016
A Proteome-Derived Longitudinal Pharmacodynamic Biomarker for Diffuse Systemic Sclerosis SkinLisa M Rice, Julio C Mantero, Giuseppina Stifano, et al.Arthritis Research & Therapy|December 17, 2015
The HLA-B*35 allele modulates ER stress, inflammation and proliferation in PBMCs from Limited Cutaneous Systemic Sclerosis patientsStefania Lenna, Shervin Assassi, G Alessandra Farina, et al.The Journal of Investigative Dermatology|August 16, 2017
Inhibition of β-Catenin Signaling in the Skin Rescues Cutaneous Adipogenesis in Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial of C-82Robert Lafyatis, Julio C Mantero, Jessica Gordon, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2018
Perivascular Adventitial Fibroblast Specialization Accompanies T Cell Retention in the Inflamed Human DermisAlexander M S Barron, Julio C Mantero, Jonathan D Ho, et al.Clinical and Experimental Rheumatology|October 3, 2018
Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I/II biomarker trialJulio C Mantero, Nina Kishore, Jessica Ziemek, et al.Arthritis Research & Therapy|August 18, 2018
Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosisLisa M Rice, Julio C Mantero, Eric A Stratton, et al.Annals of the Rheumatic Diseases|January 4, 2023
Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysisSébastien Sanges, Lisa Rice, Ly Tu, et al.Pageof 1